OPTASE ALLEGRO Eye Drops in Glance Mag

OPTASE ALLEGRO Eye Drops in Glance Magazine

As you know, dry eye is a growing problem in the US and worldwide. Reports indicate more than 117+ million Americans use eye drops at least once a year.

Scope Eyecare, a family-owned independent company based in Dublin, IR, launched OPTASE® in the US in 2019. With a Heat-Cleanse-Hydrate regimen based on DEWS II, OPTASE® strives to bring the most advanced OTC solutions to the US and a worthy partner to all eye doctors.

With over $1 billion in OTC dry eye products sold annually at national retailers in the US, OPTASE® has entered the market with an aggressive wholesale price structure allowing OD practices to increase patient compliance, increase practice revenue, offer the most advanced molecules and delivery systems to patients by stocking products in practice.

Interested? Please fill out the below information and the OPTASE® team will be in touch.

I WANT TO LEARN MORE ABOUT OPTASE ALLEGRO EYE DROPS
Title*
Name*

First NameLast Name
If Student enter School Name
If Student enter Graduation Year
Phone*
Please enter a valid phone number.
Email (If Student please enter post graduation email)*
example@example.com
Address

Street Address

Street Address Line 2

CityState / Province

Postal / Zip Code
Country
Should be Empty:

Part of the Scope Health Family

OPTASE® was launched in 2016 in conjunction with eyecare experts as part of the Scope Health Group. OPTASE® is dedicated to providing high quality, effective, and innovative products in both the eyecare and healthcare industries to patients all around the world. As we look to the future of Dry Eye and Eyecare we continue to develop new products for patients all around the world.

OPTASE ALLEGRO Eye Drops in Glance Mag